Shilpa Medicare surges on the BSE
Shilpa Medicare is currently trading at Rs 706.95, up by 12.80 points or 1.84% from its previous closing of Rs 694.15 on the BSE.
The scrip opened at Rs 700.05 and has touched a high and low of Rs 725.25 and Rs 700.05 respectively. So far 6204 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 1 has touched a 52-week high of Rs 959.95 on 18-Sep-2024 and a 52-week low of Rs 419.10 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs 725.25 and Rs 603.00 respectively. The current market cap of the company is Rs 7017.96 crore.
The promoters holding in the company stood at 44.23%, while Institutions and Non-Institutions held 18.52% and 37.25% respectively.
The United States Food and Drugs Administration (USFDA) has issued Establishment Inspection Report (EIR) to Shilpa Medicare’s 100% subsidiary -- Shilpa Pharma Lifesciences’ Unit-1 and the site is classified as Voluntary Action Indicated (VAI). The inspection was carried out at unit-1 by USFDA between March 3 to March 7, 2025.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
